8
Tetrahedron
ACCEPTED MANUSCRIPT
4.9. (2E,2'E)-3,3'-(Dibenzo[b,d]thiene-2,8-diyl)di(prop-2-enal)
°C. 1H-NMR (500 MHz, 25 °C, d6-DMSO): δ = 7.89 (dd, J1 = 8.5
Hz, J2 = 1.5 Hz, 2H, CHAR), 8.31 (d, J = 8.5 Hz, 2H, CHAR), 9.04
(d, J = 1 Hz, 2H, CHAR), 9.55 ppm (s, 2H, CH=O). 13C-NMR
(100 MHz, 25 °C, CDCl3): δ = 89.10; 95.01; 116.31; 123.64;
127.16; 131.77; 134.98; 143.10; 176.84 ppm. HR-FT-MALDI-
MS (DHB) m/z: calculated for C18H9O2S+ ([M+H]+): 289.03178;
found 289.03193.
(4a)
The title compound was prepared from aldehyde 3a (480 mg)
following the general procedure B. The product 4a was obtained
as a yellowish solid (467 mg, 80 %). Rf = 0.50 (CH2Cl2/EtOAc
1
20:1); Tm = 260 °C, Td> 320 °C. H-NMR (500 MHz, 25 °C,
d6-DMSO): δ = 7.16 (dd, J1 = 16 Hz, J2 = 8 Hz, 2H, CH),
7.94−7.97 (m, 4H, CH+CHAR), 8.23 (d, J = 8.5 Hz, 2H, CHAR),
9.10 (d, J = 1 Hz, 2H, CHAR), 9.81 ppm (d, J = 8 Hz, 2H, CH=O).
13C-NMR (125 MHz, 25 °C, d6-DMSO): δ = 122.58; 124.33;
128.68; 129.01; 131.74; 135.85; 142.43; 153.46; 194.98 ppm.
HR-FT-MALDI-MS (DHB) m/z: calculated for C18H13O2S+
([M+H]+): 293.06308; found 293.06512.
4.14. 3,3'-(5,5-Dioxo-5H-5λ6-dibenzo[b,d]thiene-2,8-
diyl)di(prop-2-ynal) (6b)
The title compound was prepared from alcohol 5b (648 mg)
following the general procedure D. The product was obtained as
a light ocher solid (480 mg, 75 %). Rf = 0.60 (CH2Cl2); Td>
230 °C. 1H-NMR (400 MHz, 25 °C, d6-DMSO): δ = 8.04 (d,
J = 7.6 Hz, 2H, CHAR), 8.24 (d, J = 8 Hz, 2H, CHAR), 8.77 (s, 2H,
CHAR), 9.56 ppm (s, 2H, CH=O). 13C-NMR (125 MHz, 25 °C,
d6-DMSO): δ = 89.82; 90.28; 123.03; 125.00; 127.82; 130.65;
135.80; 138.45; 178.75 ppm. HR-FT-MALDI-MS (DHB) m/z:
calculated for C18H9O4S+ ([M+H]+): 321.02161; found
321.02234.
4.10. (2E,2'E)-3,3'-(5,5-Dioxo-5H-5λ6-dibenzo[b,d]thiene-2,8-di-
yl)di(prop-2-enal) (4b)
The title compound was prepared from aldehyde 3b (544 mg)
following the general procedure B. After filtration step, the
column chromatography was employed to separate mono
product. The product 4b was obtained as a yellowish solid (253
mg, 39 %). Rf = 0.20 (CH2Cl2/EtOAc 20:1); Td> 350 °C.
1H-NMR (500 MHz, 25 °C, d6-DMSO): δ = 7.19 (dd, J1 = 16 Hz,
J2 = 7.5 Hz, 2H, CH), 7.93 (d, J = 15.5 Hz, 2H, CH), 8.03 (d, J =
8 Hz, 2H, CHAR), 8.19 (d, J = 7.5 Hz, 2H, CHAR), 8.83 (s, 2H,
CHAR), 9.84 ppm (d, J = 7.5 Hz, 2H,CH=O). 13C-NMR (125
MHz, 25 °C, d6-DMSO): δ = 121.78; 123.09; 131.43; 131.52;
132.65; 138.55; 140.40; 150.60; 194.88 ppm. HR-FT-MALDI-
MS (DHB) m/z: calculated for C18H13O4S+ ([M+H]+): 325.05291;
found 325.05329.
4.15. DBT-chromophore (8a)
The title chromophore was prepared from aldehyde 4a
(146 mg) following the general procedure E. The product was
obtained as a bright orange solid (287 mg, 78 %). Rf = 0.80
(CH2Cl2/Hexane 3:1); Tm = 210 °C; Td> 260 °C. 1H-NMR
(500 MHz, 25 °C, CDCl3): δ = 0.94−0.99 (m, 12H, CH3),
1.35−1.45 (m, 8H, CH2), 1.60−1.68 (m, 8H, CH2), 3.94−3.97 (m,
8H, CH2), 7.56 (d, J = 15 Hz, 2H, CH), 7.83−7.88 (m, 4H,
2×CHAR), 8.22 (d, J = 12 Hz, 2H, CH), 8.37 (s, 2H, CHAR), 8.70
ppm (dd, J1 = 15.5 Hz, J2 = 12 Hz, 2H, CH). 13C-NMR
(125 MHz, 25 °C, CDCl3): δ = 14.00; 14.04; 20.39; 20.49; 30.36;
30.43; 41.73; 42.23; 114.88; 123.25; 123.73; 125.47; 127.26;
132.66; 135.38; 143.24; 151.12; 153.73; 157.14; 161.81;
162.24 ppm. HR-FT-MALDI-MS (DHB) m/z: calculated for
C42H49N4O6S+ ([M+H]+): 737.33226; found 737.33669.
4.11. 3,3'-(Dibenzo[b,d]thiene-2,8-diyl)di(prop-2-yn-1-ol) (5a)
The title compound was prepared from bromo derivative 2a
(1.026 g) following the general procedure C. The product was
obtained as a light ocher solid (465 mg, 53 %). Rf = 0.60
1
(CH2Cl2/EtOAc 1:1); Td > 200 °C. H-NMR (500 MHz, 25 °C,
d6-DMSO): δ = 4.41 (d, J = 6 Hz, 4H, CH2), 5.47 (t, J = 6 Hz,
2H, OH), 7.61 (dd, J1 = 8 Hz, J2 = 1 Hz, 2H, CHAR), 8.11 (d,
J = 8.5 Hz, 2H, CHAR), 8.61 ppm (d, J = 0.5 Hz, 2H, CHAR).
13C-NMR (125 MHz, 25 °C, d6-DMSO): δ = 49.54; 83.66; 90.06;
119.11; 123.45; 125.26; 130.17; 134.67; 139.08 ppm. HR-FT-
MALDI-MS (DHB) m/z: calculated for C18H12O2S+ ([M]+):
292.05525; found 292.05556.
4.16. DBTO-chromophore (8b)
The title chromophore was prepared from aldehyde 4b
(162 mg) following the general procedure E. The product was
obtained as a yellow solid (185 mg, 48 %). Rf = 0.95
(CH2Cl2/EtOAc 20:1); Tm = 247 °C; Td> 270 °C. 1H-NMR
(500 MHz, 25 °C, CDCl3): δ = 0.94−0.99 (m, 12H, CH3);
1.35−1.44 (m, 8H, CH2), 1.58−1.67 (m, 8H, CH2), 3.95−3.98 (m,
8H, CH2), 7.45 (d, J = 16 Hz, 2H, CH), 7.85−7.89 (m, 4H,
2×CHAR), 8.09 (s, 2H, CHAR), 8.19 (d, J = 12 Hz, 2H, CH),
8.74 ppm (dd, J1 = 16 Hz, J2 = 12 Hz, 2H, CH). 13C-NMR
(125 MHz, 25 °C, CDCl3): δ = 13.99; 14.03; 20.37; 20.47; 30.32;
30.39; 41.90; 42.41; 117.26; 121.84; 123.18; 128.59; 130.99;
132.07; 139.34; 141.25; 149.71; 150.89; 155.41; 161.53;
161.82 ppm. HR-FT-MALDI-MS (DHB) m/z: calculated for
C42H49N4O8S+ ([M+H]+): 769.32656; found 769.32741.
4.12. 2,8-Bis(3-hydroxyprop-1-yn-1-yl)-5H-5λ6-dibenzo[b,d]thio-
phene-5,5-dione) (5b)
The title compound was prepared from bromo derivative 2b
(1.122 mg) following the general procedure C. The product was
obtained as a light ocher solid (525 mg, 54 %). Rf = 0.40
1
(CH2Cl2/EtOAc 1:1); Td > 210 °C. H-NMR (500 MHz, 25 °C,
d6-DMSO): δ = 4.43 (d, J = 6 Hz, 4H, CH2), 5.57 (t, J = 6 Hz,
2H, OH), 7.73 (d, J = 8 Hz, 2H, CHAR), 8.06 (d, J = 8 Hz, 2H,
CHAR), 8.47 ppm (s, 2H, CHAR). 13C-NMR (125 MHz, 25 °C, d6-
DMSO): δ = 49.46; 82.27; 94.07; 122.47; 125.86; 128.69;
130.82; 133.92; 136.26 ppm. HR-FT-MALDI-MS (DHB) m/z:
calculated for C18H13O4S+ ([M+H]+): 325.05291; found
325.05329.
4.17. DBT-chromophore (9a)
The title chromophore was prepared from aldehyde 6a
(144 mg) following the general procedure E. The product was
obtained as a bright yellow solid (260 mg, 71 %). Rf = 0.80
1
(CH2Cl2/Hexane 3:1); Td> 160 °C. H-NMR (500 MHz, 25 °C,
4.13. 3,3'-(Dibenzo[b,d]thiene-2,8-diyl)di(prop-2-ynal)(6a)
CDCl3): δ = 0.94−0.99 (m, 12H, CH3); 1.36−1.44 (m, 8H, CH2),
1.61−1.69 (m, 8H, CH2), 3.94−4.00 (m, 8H, CH2), 7.80 (dd,
J1 = 8.5 Hz, J2 = 1.5 Hz, 2H, CHAR), 7.84 (s, 2H, CH), 7.91 (d,
J = 8 Hz, 2H, CHAR), 8.49 ppm (d, J = 1 Hz, 2H, CHAR). 13C-
The title compound was prepared from alcohol 5a (584 mg)
following the general procedure D. The product was obtained as
a light orange solid (253 mg, 44 %). Rf = 0.85 (CH2Cl2); Td> 215